Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,125,160    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,064,010      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $880,932 Immunome Inc. $109,656 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $880,932 Immunome Inc. $109,656
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 28 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-12 4/A D $67.68 $591,659 D/D (8,742) 102,165 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-06-05 4 OE $58.68 $593,406 I/I 10,000 43,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-02-18 4 AS $85.08 $595,560 D/D (7,000) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-06-03 4 D $90.00 $597,600 D/D (6,640) 378,584 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-12 4 D $67.68 $600,525 D/D (8,873) 102,165 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-06-02 4 D $90.72 $602,381 D/D (6,640) 226,924 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-15 4 D $122.78 $605,551 D/D (4,932) 235,894 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-06-04 4 OE $60.72 $607,194 I/I 10,000 43,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-10-31 4 AS $62.72 $627,155 I/I (10,000) 45,740 0 -
ITMN InterMune Inc Director   –       •      –    2014-09-29 4 D $74.00 $630,850 D/D (8,525) 1,200 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2023-12-21 4 OE $63.10 $631,000 D/D 10,000 435,112 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-01-09 4 OE $63.10 $631,000 D/D 10,000 435,162 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-01-10 4 OE $63.10 $631,000 D/D 10,000 435,162 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-02-20 4 AS $80.00 $640,000 I/I (8,000) 46,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-02-13 4 AS $109.15 $654,900 D/D (6,000) 320,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-05-31 4 AS $88.29 $655,377 D/D (7,423) 233,564 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-05-10 4 AS $77.29 $657,970 D/D (8,513) 303,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-05-06 4 OE $26.49 $662,250 D/D 25,000 328,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-05-07 4 OE $26.49 $662,250 D/D 25,000 328,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-08 4 D $121.66 $666,575 D/D (5,479) 243,175 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2014-01-06 4 AS $67.40 $674,096 I/I (10,000) 50,740 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-02-17 4 AS $84.54 $676,320 D/D (8,000) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-01-13 4 OE $67.81 $678,100 D/D 10,000 330,424 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-01-17 4 OE $67.81 $678,100 D/D 10,000 330,424 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-04-06 4 OE $67.81 $678,100 D/D 10,000 435,896 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28  29   30   31   32   33   34      
  Page 28 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us